SOPHARMA AD hereby informs that on 21 September 2017 the Company bought 6635 own shares representing 0.0049% of the share capital of the Company, at a total value of 28750.33.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.33 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

SOPHARMA AD hereby informs that from 20 September 2017 the Company bought 5650 own shares representing 0.0042% of the share capital of the Company, at a total value of 24 441.00 BGN on the Bulgarian Stock Exchange, the average price per share was 4.33 BGN.

The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010.

Sopharma AD notifies that from 18 September 2017 up to and including 19 September 2017 Sopharma AD acquired 12 927 shares from the capital of Unipharm AD as a result of filed requests under the provisions of art. 157b from the LOPS.

The term under art. 157b expired on 19 September 2017.